Trial Profile
Pantoprazole 20/40 mg in Reflux-Associated Complaints With Focus on Gastrointestinal Symptoms.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Dec 2014
Price :
$35
*
At a glance
- Drugs Pantoprazole (Primary)
- Indications Gastro-oesophageal reflux
- Focus Therapeutic Use
- Acronyms PARADE
- Sponsors Takeda Pharmaceuticals International GmbH
- 07 May 2012 Company (Takeda Pharmaceuticals International GmbH) added in the association field as reported by ClinicalTrials.gov.
- 07 May 2012 Additional lead trial centre (Takeda Pharmaceuticals International GmbH) identified as reported by ClinicalTrials.gov.
- 07 May 2012 Company (Takeda Global Research and Development Center) added as reported by ClinicalTrials.gov.